Highest-materiality recent filing
Callan JMB enters $5M ATM equity offering with Alexander Capital
Up to $5M of common stock may be sold through agent Alexander Capital in at-the-market offerings.
Callan JMB receives Nasdaq delisting notice for insufficient stockholders' equity
Nasdaq notified Callan JMB it fails minimum $2.5M stockholders' equity requirement (Rule 5550(b)(1)).
Callan JMB reports FY 2025 revenue down 14% to $5.7M; operating loss widens to $7.0M
Revenue $5.7M vs $6.6M in 2024; gross profit $2.1M vs $2.6M.
Callan JMB amends Hexstone equity line: maturity extended, purchase price lowered to 95% of low
Maturity date extended to April 1, 2027.
Callan JMB to present at DealFlow Discovery Conference Jan 28; no financial details in filing
Company plans to make investor presentations at the DealFlow Discovery Conference starting January 28, 2026.
Callan JMB shareholders elect all 5 director nominees, ratify auditor
3,171,618 shares (~68.60% of outstanding) represented at Dec 29 annual meeting.
Callan JMB amends insider trading policy with adjusted blackout period
Board adopted amended insider trading policy on December 8, 2025.
Callan JMB appoints Christopher Shields as Interim CFO effective Dec 1, 2025
Christopher Shields, age 57, appointed Interim CFO effective Dec 1, 2025; continues as SVP Governmental Affairs.
Callan JMB Q3 revenue $1.4M, operating loss $1.9M; expands into food sampling and India
Revenue $1.4M Q3, $4.6M YTD; operating loss $1.9M Q3, $4.5M YTD.
Q2 2025 revenue $1.7M, down YoY; H1 revenue $3.1M; gross profit $0.6M and $1.3M respectively.
Callan JMB secures $25M equity line-of-credit with single investor at 95% of VWAP
Entered Purchase Agreement effective July 24, 2025, for up to $25 million in common stock sales over 18 months.
Callan JMB Q1 net loss $1.2M, revenue $1.45M; CFO Appleman terminated for cause
Revenue $1.45M, down due to lower emergency preparedness demand; gross margin 42.5%.
Callan JMB completes IPO of 1.44M shares at $4.00, net $4.73M; adds 3 directors
IPO of 1,280,000 shares at $4.00/share for gross $5.12M; partial over-allotment of 163,569 shares, total 1,443,569 shares issued.
Effective as of May 13, 2025, the Company terminated Chief Financial Officer, Jeffrey A. Appleman, effective immediately.
On May 14, 2025, Shannon Badger, age 41, was appointed and named as the interim Chief Financial Officer of the Company, effective immediately.
On February 4, 2025, the Company appointed three directors (the “New Directors”) to its board of directors (the “Board of Directors”). The New Directors are Liberty Duke, Mark Meller and Gerald Dial.
On February 4, 2025, the Company appointed three directors (the “New Directors”) to its board of directors (the “Board of Directors”). The New Directors are Liberty Duke, Mark Meller and Gerald Dial.
On February 4, 2025, the Company appointed three directors (the “New Directors”) to its board of directors (the “Board of Directors”). The New Directors are Liberty Duke, Mark Meller and Gerald Dial.
Max materiality 0.75 · Median 0.60 · Most common event other_material